首页 > 最新文献

Chinese journal of cancer research = Chung-kuo yen cheng yen chiu最新文献

英文 中文
National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version). 《2022年中国乳腺癌诊疗指南》(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.02
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of breast cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.02","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.02","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"151-175"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273574/pdf/cjcr-34-3-151.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533658","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version). 中国国家前列腺癌诊疗指南2022(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.07
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of prostate cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.07","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.07","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"270-288"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273581/pdf/cjcr-34-3-270.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version). 中国国家甲状腺癌诊疗指南2022(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.01
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of thyroid cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.01","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.01","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"131-150"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273579/pdf/cjcr-34-3-131.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40644801","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 6
National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version). 中国国家胃癌诊疗指南2022(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.04
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of gastric cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.04","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.04","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"207-237"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273576/pdf/cjcr-34-3-207.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40644802","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 10
National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version). 中国国家宫颈癌诊疗指南2022(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.06
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of cervical cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.06","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.06","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"256-269"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273580/pdf/cjcr-34-3-256.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress. 晚期乳腺癌患者的症状负担及其死亡焦虑与心理困扰的关系
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.09
Zhongge Su, Yuhe Zhou, Xinkun Han, Ying Pang, Shuangzhi He, Lili Tang

Objective: Recent research has documented psychological distress in advanced breast cancer (ABC) patients, but few studies have examined how death anxiety is affected by the symptom burden. Therefore, this study aims to explore the association among symptom burden, death anxiety and psychological distress (depression and anxiety) in ABC patients.

Methods: This cross-sectional study used the Death and Dying Anxiety Scale (DADDS), 9-item Patient Health Questionnaire (PHQ-9), General Anxiety Disorder-7 (GAD-7) and MD Anderson Symptom Inventory (MDASI) to assess death anxiety, depression, anxiety, and symptom burden, respectively. Bias-corrected bootstrapping methods were used to estimate indirect effects and 95% confidence intervals.

Results: Two hundred ABC patients completed the questionnaires. All of the respondents were females, with a mean age of 50±10 years. Initial correlation analyses revealed significant associations of death anxiety with depression (r=0.57, P<0.001), anxiety (r=0.60, P<0.001) and symptom burden (r=0.43, P<0.001). Moreover, depression (r=0.53, P<0.001) and anxiety (r=0.45, P<0.001) were significantly correlated with symptom burden. An analysis using Hayes' PROCESS macro revealed the partial effecting role of death anxiety in the relationship between depression and symptom burden, and between anxiety and symptom burden (contributions to the total effect of 0.247 and 0.469, respectively).

Conclusions: This study provides insight into the relationship between death anxiety and symptom burden. The results suggest that interventions addressing death anxiety may be more effective for alleviating the depression and anxiety experienced by ABC patients with a symptom burden.

目的:最近的研究证实了晚期乳腺癌(ABC)患者的心理困扰,但很少有研究探讨死亡焦虑如何受到症状负担的影响。因此,本研究旨在探讨ABC患者的症状负担、死亡焦虑和心理困扰(抑郁和焦虑)之间的关系。方法:采用死亡与临终焦虑量表(dadd)、9项患者健康问卷(PHQ-9)、一般焦虑障碍-7 (GAD-7)和MD安德森症状量表(MDASI)分别评估死亡焦虑、抑郁、焦虑和症状负担。偏差校正的自举方法用于估计间接效应和95%置信区间。结果:200例ABC患者完成问卷调查。调查对象均为女性,平均年龄50±10岁。初步相关分析显示,死亡焦虑与抑郁之间存在显著相关性(r=0.57, p)。结论:本研究揭示了死亡焦虑与症状负担之间的关系。结果表明,针对死亡焦虑的干预措施可能更有效地减轻ABC患者的抑郁和焦虑。
{"title":"Symptom burden in advanced breast cancer patients and its association between death anxiety and psychological distress.","authors":"Zhongge Su,&nbsp;Yuhe Zhou,&nbsp;Xinkun Han,&nbsp;Ying Pang,&nbsp;Shuangzhi He,&nbsp;Lili Tang","doi":"10.21147/j.issn.1000-9604.2022.03.09","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.09","url":null,"abstract":"<p><strong>Objective: </strong>Recent research has documented psychological distress in advanced breast cancer (ABC) patients, but few studies have examined how death anxiety is affected by the symptom burden. Therefore, this study aims to explore the association among symptom burden, death anxiety and psychological distress (depression and anxiety) in ABC patients.</p><p><strong>Methods: </strong>This cross-sectional study used the Death and Dying Anxiety Scale (DADDS), 9-item Patient Health Questionnaire (PHQ-9), General Anxiety Disorder-7 (GAD-7) and MD Anderson Symptom Inventory (MDASI) to assess death anxiety, depression, anxiety, and symptom burden, respectively. Bias-corrected bootstrapping methods were used to estimate indirect effects and 95% confidence intervals.</p><p><strong>Results: </strong>Two hundred ABC patients completed the questionnaires. All of the respondents were females, with a mean age of 50±10 years. Initial correlation analyses revealed significant associations of death anxiety with depression (r=0.57, P<0.001), anxiety (r=0.60, P<0.001) and symptom burden (r=0.43, P<0.001). Moreover, depression (r=0.53, P<0.001) and anxiety (r=0.45, P<0.001) were significantly correlated with symptom burden. An analysis using Hayes' PROCESS macro revealed the partial effecting role of death anxiety in the relationship between depression and symptom burden, and between anxiety and symptom burden (contributions to the total effect of 0.247 and 0.469, respectively).</p><p><strong>Conclusions: </strong>This study provides insight into the relationship between death anxiety and symptom burden. The results suggest that interventions addressing death anxiety may be more effective for alleviating the depression and anxiety experienced by ABC patients with a symptom burden.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"298-308"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273575/pdf/cjcr-34-3-298.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533663","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction. 近端胃切除术后Cheng's GIRAFFE重建治疗食管胃交界腺癌的疗效分析。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.08
Zhiyuan Xu, Can Hu, Yanqiang Zhang, Ling Huang, Litao Yang, Jianfa Yu, Pengfei Yu, Jiahui Chen, Yian Du, Xiangdong Cheng

Objective: Reconstruction of the digestive tract for adenocarcinoma of esophagogastric junction (AEG) is in dispute. This study evaluated Cheng's gastric tube interposition esophagogastrostomy with reconstruction of His angle and fundus (Cheng's GIRAFFE anastomosis) in laparoscopic/open proximal gastrectomy for Siewert type II AEG, which was performed at Zhejiang Cancer Hospital and the First Affiliated Hospital of Zhejiang Chinese Medical University. Here, we discuss the preliminary results of gastric emptying and anti-reflux.

Methods: From a retrospective database, 74 patients with advanced Siewert type II AEG underwent curative proximal gastrectomy with GIRAFFE anastomosis, and their gastric emptying and anti-reflux outcomes were evaluated by the Reflux Disease Questionnaire (RDQ) score, nuclide gastric emptying, 24-h impedance-pH monitoring and gastroscopy.

Results: Seventy-four patients successfully completed proximal partial gastrectomy with Cheng's GIRAFFE esophagogastric anastomosis. RDQ score six months after the operation was 2.2±2.5. Results of nuclide gastric emptying examinations showed that the gastric half-emptying time was 67.0±21.5 min, the 1-h residual rate was (52.2±7.7)%, the 2-h residual rate was (36.4±5.1)%, and the 3-h residual rate was (28.8±3.6)%; 24-h impedance-pH monitoring revealed that the mean DeMeester score was 5.8±2.9. Reflux esophagitis was observed by gastroscopy in 7 patients six months after surgery.

Conclusions: Cheng's GIRAFFE anastomosis is safe and feasible for Siewert type II AEG.

目的:食管胃交界腺癌(AEG)的消化道重建存在争议。本研究评价在浙江肿瘤医院、浙江中医药大学第一附属医院行腹腔镜/开放式胃近端切除术治疗siwert II型AEG的Cheng胃管插入式食管胃造口术及he角和眼底重建(Cheng GIRAFFE吻合)。在这里,我们讨论胃排空和抗反流的初步结果。方法:回顾性分析74例晚期Siewert II型AEG患者行根治性胃近端切除术,采用GIRAFFE吻合术,通过反流疾病问卷(RDQ)评分、核素胃排空、24小时阻抗- ph监测和胃镜检查评估其胃排空和抗反流结果。结果:74例患者采用Cheng氏GIRAFFE食管胃吻合术成功完成近端胃部分切除术。术后6个月RDQ评分为2.2±2.5。核素胃排空检查结果显示,胃半排空时间为67.0±21.5 min, 1 h残留率为(52.2±7.7)%,2 h残留率为(36.4±5.1)%,3 h残留率为(28.8±3.6)%;24 h阻抗- ph监测显示,平均DeMeester评分为5.8±2.9。7例患者术后6个月胃镜观察到反流性食管炎。结论:Cheng氏GIRAFFE吻合术用于Siewert II型AEG是安全可行的。
{"title":"Efficacy analysis of Cheng's GIRAFFE reconstruction after proximal gastrectomy for adenocarcinoma of esophagogastric junction.","authors":"Zhiyuan Xu,&nbsp;Can Hu,&nbsp;Yanqiang Zhang,&nbsp;Ling Huang,&nbsp;Litao Yang,&nbsp;Jianfa Yu,&nbsp;Pengfei Yu,&nbsp;Jiahui Chen,&nbsp;Yian Du,&nbsp;Xiangdong Cheng","doi":"10.21147/j.issn.1000-9604.2022.03.08","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.08","url":null,"abstract":"<p><strong>Objective: </strong>Reconstruction of the digestive tract for adenocarcinoma of esophagogastric junction (AEG) is in dispute. This study evaluated Cheng's gastric tube interposition esophagogastrostomy with reconstruction of His angle and fundus (Cheng's GIRAFFE anastomosis) in laparoscopic/open proximal gastrectomy for Siewert type II AEG, which was performed at Zhejiang Cancer Hospital and the First Affiliated Hospital of Zhejiang Chinese Medical University. Here, we discuss the preliminary results of gastric emptying and anti-reflux.</p><p><strong>Methods: </strong>From a retrospective database, 74 patients with advanced Siewert type II AEG underwent curative proximal gastrectomy with GIRAFFE anastomosis, and their gastric emptying and anti-reflux outcomes were evaluated by the Reflux Disease Questionnaire (RDQ) score, nuclide gastric emptying, 24-h impedance-pH monitoring and gastroscopy.</p><p><strong>Results: </strong>Seventy-four patients successfully completed proximal partial gastrectomy with Cheng's GIRAFFE esophagogastric anastomosis. RDQ score six months after the operation was 2.2±2.5. Results of nuclide gastric emptying examinations showed that the gastric half-emptying time was 67.0±21.5 min, the 1-h residual rate was (52.2±7.7)%, the 2-h residual rate was (36.4±5.1)%, and the 3-h residual rate was (28.8±3.6)%; 24-h impedance-pH monitoring revealed that the mean DeMeester score was 5.8±2.9. Reflux esophagitis was observed by gastroscopy in 7 patients six months after surgery.</p><p><strong>Conclusions: </strong>Cheng's GIRAFFE anastomosis is safe and feasible for Siewert type II AEG.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"289-297"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273578/pdf/cjcr-34-3-289.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533661","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version). 中国国家胰腺癌诊疗指南2022(英文版)。
Pub Date : 2022-06-30 DOI: 10.21147/j.issn.1000-9604.2022.03.05
National Health Commission Of The People's Republic Of China
{"title":"National guidelines for diagnosis and treatment of pancreatic cancer 2022 in China (English version).","authors":"National Health Commission Of The People's Republic Of China","doi":"10.21147/j.issn.1000-9604.2022.03.05","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2022.03.05","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"34 3","pages":"238-255"},"PeriodicalIF":0.0,"publicationDate":"2022-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9273582/pdf/cjcr-34-3-238.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40533662","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 3
Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations. 开发并验证基于问卷的风险评分系统,以识别中国人群中的胃癌高危人群。
Pub Date : 2021-12-31 DOI: 10.21147/j.issn.1000-9604.2021.06.02
Ren Zhou, Hongchen Zheng, Mengfei Liu, Zhen Liu, Chuanhai Guo, Hongrui Tian, Fangfang Liu, Ying Liu, Yaqi Pan, Huanyu Chen, Zhe Hu, Hong Cai, Zhonghu He, Yang Ke

Objective: This study aimed to develop and validate a risk scoring system to identify high-risk individuals carrying malignant lesions in stomach for tailored gastric cancer screening.

Methods: A gastric cancer risk scoring system (GC-RSS) was developed based on questionnaire-based predictors for gastric cancer derived from systematic literature review. To assess the capability of this system for discrimination, risk scores for 8,214 and 7,235 outpatient subjects accepting endoscopic examination in two endoscopy centers, and 32,630 participants in a community-based cohort in China were calculated to plot receiver operating characteristic curves and generate area under the curve (AUC). To evaluate the performance of GC-RSS, the screening proportion, sensitivity and detection rate ratio compared to universal screening were used under different risk score cutoff values.

Results: GC-RSS comprised nine predictors including advanced age, male gender, low body mass index (<18.5 kg/m2), family history of gastric cancer, cigarette smoking, consumption of alcohol, preference for salty food, irregularity of meals and consumption of preserved food. This tool performed well in determining the risk of malignant gastric lesions with AUCs of 0.763, 0.706 and 0.696 in three validation sets. When subjects with risk scores ≥5 were evaluated with endoscopy, nearly 50% of these endoscopies could be saved with a detection rate of over 1.5 times achieved. When the cutoff was set at 8, only about 10% of subjects with the highest risk would be offered endoscopy, and detection rates for gastric cancer could be increased 2-4 fold compared to universal screening.

Conclusions: An effective questionnaire-based GC-RSS was developed and validated. This tool may play an important role in establishing a tailored screening strategy for gastric cancer in China.

研究目的本研究旨在开发并验证一种风险评分系统,以识别胃部恶性病变的高危人群,从而进行有针对性的胃癌筛查:方法:根据系统性文献回顾中得出的胃癌预测指标,以问卷为基础开发了胃癌风险评分系统(GC-RSS)。为了评估该系统的判别能力,计算了在两家内镜中心接受内镜检查的8214名门诊患者和7235名门诊患者的风险评分,以及中国社区队列中32630名参与者的风险评分,绘制接收器操作特征曲线并生成曲线下面积(AUC)。为了评估 GC-RSS 的性能,采用了在不同风险评分临界值下与普遍筛查相比的筛查比例、灵敏度和检出率比值:GC-RSS 包含九项预测因素,包括高龄、男性、低体重指数 (2)、胃癌家族史、吸烟、饮酒、偏好咸味食物、三餐不定时和食用腌制食品。该工具在确定胃恶性病变风险方面表现良好,三个验证集的AUC分别为0.763、0.706和0.696。当风险评分≥5分的受试者接受内镜检查时,近50%的内镜检查可以节省,检出率超过1.5倍。当临界值设定为8时,只有约10%的高风险受试者会接受内镜检查,而胃癌的检出率可比普遍筛查提高2-4倍:结论:我们开发并验证了一种有效的基于调查问卷的胃癌筛查系统(GC-RSS)。结论:基于问卷的 GC-RSS 已被开发并验证,该工具可在中国建立有针对性的胃癌筛查策略中发挥重要作用。
{"title":"Development and validation of a questionnaire-based risk scoring system to identify individuals at high risk for gastric cancer in Chinese populations.","authors":"Ren Zhou, Hongchen Zheng, Mengfei Liu, Zhen Liu, Chuanhai Guo, Hongrui Tian, Fangfang Liu, Ying Liu, Yaqi Pan, Huanyu Chen, Zhe Hu, Hong Cai, Zhonghu He, Yang Ke","doi":"10.21147/j.issn.1000-9604.2021.06.02","DOIUrl":"10.21147/j.issn.1000-9604.2021.06.02","url":null,"abstract":"<p><strong>Objective: </strong>This study aimed to develop and validate a risk scoring system to identify high-risk individuals carrying malignant lesions in stomach for tailored gastric cancer screening.</p><p><strong>Methods: </strong>A gastric cancer risk scoring system (GC-RSS) was developed based on questionnaire-based predictors for gastric cancer derived from systematic literature review. To assess the capability of this system for discrimination, risk scores for 8,214 and 7,235 outpatient subjects accepting endoscopic examination in two endoscopy centers, and 32,630 participants in a community-based cohort in China were calculated to plot receiver operating characteristic curves and generate area under the curve (AUC). To evaluate the performance of GC-RSS, the screening proportion, sensitivity and detection rate ratio compared to universal screening were used under different risk score cutoff values.</p><p><strong>Results: </strong>GC-RSS comprised nine predictors including advanced age, male gender, low body mass index (<18.5 kg/m<sup>2</sup>), family history of gastric cancer, cigarette smoking, consumption of alcohol, preference for salty food, irregularity of meals and consumption of preserved food. This tool performed well in determining the risk of malignant gastric lesions with AUCs of 0.763, 0.706 and 0.696 in three validation sets. When subjects with risk scores ≥5 were evaluated with endoscopy, nearly 50% of these endoscopies could be saved with a detection rate of over 1.5 times achieved. When the cutoff was set at 8, only about 10% of subjects with the highest risk would be offered endoscopy, and detection rates for gastric cancer could be increased 2-4 fold compared to universal screening.</p><p><strong>Conclusions: </strong>An effective questionnaire-based GC-RSS was developed and validated. This tool may play an important role in establishing a tailored screening strategy for gastric cancer in China.</p>","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"33 6","pages":"649-658"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/56/93/cjcr-33-6-649.PMC8742173.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39770199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review. 将病理学与放射组学和基因组学结合用于癌症预后:简要回顾。
Pub Date : 2021-12-31 DOI: 10.21147/j.issn.1000-9604.2021.06.09
{"title":"Corrigendum to Integrating pathomics with radiomics and genomics for cancer prognosis: A brief review.","authors":"","doi":"10.21147/j.issn.1000-9604.2021.06.09","DOIUrl":"https://doi.org/10.21147/j.issn.1000-9604.2021.06.09","url":null,"abstract":"","PeriodicalId":9830,"journal":{"name":"Chinese journal of cancer research = Chung-kuo yen cheng yen chiu","volume":"33 6","pages":"724"},"PeriodicalIF":0.0,"publicationDate":"2021-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/02/d5/cjcr-33-6-724.PMC8742174.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"39596573","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Chinese journal of cancer research = Chung-kuo yen cheng yen chiu
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1